Skip to content

Diabetic Retinopathy Prevalence And Risk Factors

Diabetic Retinopathy Prevalence And Risk Factors From A Hospital - Based Cohort In Central Vietnam

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07468058
Acronym
DR-CENTRAL
Enrollment
300
Registered
2026-03-12
Start date
2025-11-25
Completion date
2026-03-30
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy (DR)

Brief summary

The goal of this retrospective observational study is to evaluate the prevalence and severity of diabetic retinopathy (DR) and to identify associated risk factors among patients with diabetes mellitus at Gia Dinh Family Hospital in Da Nang, Vietnam. The main questions it aims to answer are: 1. What is the prevalence and distribution of different stages of diabetic retinopathy among diabetic patients at this hospital? 2. Which clinical and laboratory factors are associated with the presence of diabetic retinopathy?

Detailed description

Diabetic retinopathy (DR) is a leading cause of preventable visual impairment worldwide. Global estimates suggest that approximately 22-26% of people with diabetes have some degree of DR, with about 6% experiencing vision-threatening disease. The burden is expected to increase substantially, particularly in low- and middle-income countries. Vietnam is experiencing a rapid rise in diabetes prevalence, however, data from Central Vietnam, particularly from multidisciplinary general hospitals, remain limited. This study aims to evalutate the local prevalence, severity distribution, and associated risk factors of DR in a general hospital in Da Nang which is essential to inform screening strategies, optimize management, and reduce preventable vision loss.

Interventions

OTHERfundus examination and optical coherence tomography (OCT)

Patients will be identified through the Ehealth program at the Family Hospital, Da Nang. All diabetic patients who visited the Center of Endocrinology and Diabetes and had ophthalmologic examination, including fundus examination and optical coherence tomography (OCT), during the study period will be screened for eligibility

Sponsors

Da Nang Family General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed diabetes mellitus (type 1 or type 2) according to ADA criteria * Underwent ophthalmic examination including dilated fundus examination and OCT * Available electronic medical records with key clinical and laboratory data

Exclusion criteria

* Gestational diabetes mellitus * Media opacity precluding fundus examination (advanced cataract, corneal opacity, dense vitreous hemorrhage) * Other retinal diseases (e.g., hypertensive retinopathy, retinal vein occlusion) * History of ocular trauma or intraocular surgery within 6 months

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of diabetic retinopathy (any stage)At baseline (data collected at the time of retinal examination during the study period, January-September 2025)To determine the prevalence of diabetic retinopathy among patients with diabetes mellitus.

Countries

Vietnam

Contacts

CONTACTThảo Nguyễn, MD
ngocthao090897@gmail.com84335393897
PRINCIPAL_INVESTIGATORThao Nguyen Ngoc, Doctor of Medicine

Family Hospital, Da Nang, Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026